Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer Medicine|November 3, 2020
The SIMM study: Survey of integrative medicine in myeloproliferative neoplasmsKrisstina Gowin, Blake T Langlais, Heidi E Kosiorek, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 3, 2019
Neuropsychological decline up to 20 years before incident mild cognitive impairmentRichard J Caselli, Blake T Langlais, Amylou C Dueck, et al.
Journal of Clinical & Translational Endocrinology|July 29, 2025
Enrollment in a fracture liaison service does not guarantee post fracture follow-upCraig R Jenkins, Jessica D Collier, Claire I Yee, et al.
Journal of the American Geriatrics Society|January 18, 2018
Personality Changes During the Transition from Cognitive Health to Mild Cognitive ImpairmentRichard J Caselli, Blake T Langlais, Amylou C Dueck, et al.
Leukemia & Lymphoma|January 18, 2019
Item nonresponse on the Myeloproliferative Neoplasms Symptom Assessment Form (MPN-SAF): a comparison of missing data strategiesGina L Mazza, Katie L Kunze, Blake T Langlais, et al.
Cancer Medicine|September 25, 2020
Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex conditionLeslie Padrnos, Robyn Scherber, Holly Geyer, et al.
JTCVS Open|January 11, 2024
Early national trends of lung allograft use during donation after circulatory death heart procurement in the United StatesKukbin Choi, Cristiano Spadaccio, Rafaela V P Ribeiro, et al.
Contemporary Clinical Trials Communications|September 24, 2025
Use of patient-reported outcomes version of the common terminology criteria for adverse events in oncology clinical trialsLauren Rogak, Jamie K Forschmiedt, Ethan Basch, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 22, 2021
Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2Gina L Mazza, Molly M Petersen, Brenda Ginos, et al.
Cancer|October 22, 2025
Methods for implementing and reporting the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events to measure patient-reported adverse events in cancer clinical trialsAmylou C Dueck, Gita Thanarajasingam, Lauren Rogak, et al.
Pageof 3